跳至主要内容
临床试验/NCT05286099
NCT05286099Unknown不适用

The Surveillance of Development and Progression of Hepatocellular Carcinoma

Chinese PLA General Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
Effective detection of early hepatocellular carcinoma

研究概览

简要总结

Early detection of hepatocellular carcinoma is vita to the prognosis of patient. In this study, the occurrence and development of liver cancer were supervised by imaging examination, and the dysplastic nodules will be distinguished from early hepatocellular carcinoma through macro-imaging and micro-pathological features.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Hepatitis B and cirrhosis Accept regular imaging examination. Pathological diagnosis of liver cancer.

排除标准

  • Can't tolerate the enhanced imaging examination Poor medical compliance

结局指标

主要结局

Effective detection of early hepatocellular carcinoma

时间窗: 2 years

The occurrence of early hepatocellular carcinoma

次要结局

未报告次要终点

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ping Liang

Chinese PLA General Hospital

Chinese PLA General Hospital

研究点 (2)

Loading locations...

相似试验